FEDERAL LOBBYING RECORDS
LOBBYING FILINGS AND MARKET CONTEXT
Indexed federal lobbying filings mapped to clients, registrants, and public-company tickers. Transaction dates are compared with filing periods to identify date-proximity review flags. Proximity does not establish coordination, influence, or wrongdoing.
Filings tracked
20,641
thru 2026-07-15
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,260
paying companies
Tickers targeted
1,219
public companies
Clients by reported amount
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 48 | $46.9M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 13 | $45.0M |
| 4 | VISA INC.V | 46 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 37 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 76 | $29.1M |
| 7 |  FEDEX CORPORATIONFDXW | 71 | $27.9M |
| 8 |  ELI LILLY AND COMPANYLLY | 60 | $27.4M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 147 | $25.3M |
| 10 |  COMCAST CORPORATIONCMCSV | 183 | $24.9M |
| 11 |  AMGEN INCAMGN | 19 | $24.9M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 54 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 83 | $22.8M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 131 | $21.3M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 41 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 32 | $19.8M |
| 20 |  MICROSOFT CORPORATIONMSFT | 107 | $18.9M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  BOEING COMPANYBA | 24 | $17.0M |
| 23 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 60 | $16.8M |
Mapped tickers by reported amount
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 134 | $50.3M |
| 2 | PFE Pfizer Inc. | 89 | $48.7M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 47 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 82 | $35.4M |
| 6 | LMT Lockheed Martin Corporation | 92 | $29.5M |
| 7 | FDX FedEx Corporation | 83 | $28.4M |
| 8 | LLY Eli Lilly and Company | 88 | $28.4M |
| 9 | AMGN Amgen Inc. | 100 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 66 | $27.0M |
| 12 | GOOGL Alphabet Inc. Class A | 128 | $26.8M |
| 13 | MO | 172 | $26.4M |
| 14 | SO Southern Company | 110 | $26.2M |
| 15 | UNH UnitedHealth Group Inc. | 68 | $24.0M |
| 16 | VZ Verizon Communications Inc. | 119 | $23.8M |
| 17 | TMUS | 170 | $22.9M |
| 18 |  CHTR | 142 | $22.8M |
| 19 | GD General Dynamics Corporation | 131 | $22.6M |
| 20 |  TAT&T Inc. | 137 | $21.7M |
| 21 | ORCL Oracle Corporation | 135 | $20.8M |
| 22 | CMCSA Comcast Corporation | 142 | $20.5M |
| 23 | OXY Occidental Petroleum Corporation | 38 | $20.1M |
| 24 | CI The Cigna Group | 64 | $19.9M |
| 25 | MSFT Microsoft Corporation | 126 | $19.3M |
🆕 Filtered Filings · BECTON DICKINSON AND COMPANY
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-20 | BDX | BECTON DICKINSON AND COMPANY | BECTON, DICKINSON AND COMPANY | $755K | Issues related to medical device supply chain Issues related to international trade Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS proposed rule and ANPRM on PPE and essential medicines Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to women's health Issues related to diagnostic testing Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization |
| 2026-04-20 | BDX | BECTON DICKINSON AND COMPANY | BGR GOVERNMENT AFFAIRS | $80K | Provide strategic counsel and advocate on issues related to medical device regulation, supply chains and trade |
| 2026-04-19 | BDX | BECTON DICKINSON AND COMPANY | DCI GROUP, L.L.C. | $60K | Provide strategic counsel and advocate on issues related to medical device regulation. |
| 2026-04-06 | BDX | BECTON DICKINSON AND COMPANY | SQUIRE PATTON BOGGS | $0 | |
| 2026-01-20 | BDX | BECTON DICKINSON AND COMPANY | BGR GOVERNMENT AFFAIRS | $80K | Provide strategic counsel and advocate on issues related to medical device regulation, supply chains and trade |
| 2026-01-20 | BDX | BECTON DICKINSON AND COMPANY | DCI GROUP, L.L.C. | $60K | Provide strategic counsel and advocate on issues related to medical device regulation. |
| 2026-01-15 | BDX | BECTON DICKINSON AND COMPANY | BECTON, DICKINSON AND COMPANY | $1.5M | Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to women's health Issues related to diagnostic testing Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization Issues related to medical device supply chain Issues related to international trade Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS proposed rule |
| 2026-01-12 | BDX | BECTON DICKINSON AND COMPANY | SQUIRE PATTON BOGGS | $0 | |
| 2025-11-13 | BDX | BECTON DICKINSON AND COMPANY | DCI GROUP, L.L.C. | $0 | Provide strategic counsel and advocate on issues related to medical device regulation, supply chains, and trade |
| 2025-10-20 | BDX | BECTON DICKINSON AND COMPANY | BGR GOVERNMENT AFFAIRS | $90K | Provide strategic counsel and advocate on issues related to medical device regulation, supply chains and trade |
| 2025-10-17 | BDX | BECTON DICKINSON AND COMPANY | BECTON, DICKINSON AND COMPANY | $550K | Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to women's health Issues related to diagnostic testing Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization Issues related to medical device supply chain Issues related to international trade Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS proposed rule |
| 2025-10-14 | BDX | BECTON DICKINSON AND COMPANY | BECTON, DICKINSON AND COMPANY | $1.4M | Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization Issues related to medical device supply chain |
| 2025-10-14 | BDX | BECTON DICKINSON AND COMPANY | SQUIRE PATTON BOGGS | $0 | |
| 2025-09-15 | BDX | BECTON DICKINSON AND COMPANY | BECTON, DICKINSON AND COMPANY | $557K | Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization Issues related to medical device supply chain |
| 2025-07-21 | BDX | BECTON DICKINSON AND COMPANY | BECTON, DICKINSON AND COMPANY | $557K | Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization Issues related to medical device supply chain |
| 2025-07-21 | BDX | BECTON DICKINSON AND COMPANY | BGR GOVERNMENT AFFAIRS | $120K | Provide strategic counsel and advocate on issues related to medical device regulation, supply chains and trade |
| 2025-07-21 | BDX | BECTON DICKINSON AND COMPANY | KING & SPALDING LLP | $40K | Issues affecting manufacturer and direct supplier of medical products and diagnostics, including access, reimbursement, and supply chain considerations. |
| 2025-07-17 | BDX | BECTON DICKINSON AND COMPANY | SQUIRE PATTON BOGGS | $0 | |
| 2025-04-21 | BDX | BECTON DICKINSON AND COMPANY | BECTON, DICKINSON AND COMPANY | $1.3M | Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization Issues related to medical device supply chain |
| 2025-04-21 | BDX | BECTON DICKINSON AND COMPANY | BGR GOVERNMENT AFFAIRS | $80K | Provide strategic counsel and advocate on issues related to medical device regulation, supply chains and trade |
| 2025-04-21 | BDX | BECTON DICKINSON AND COMPANY | KING & SPALDING LLP | $60K | Issues affecting manufacturer and direct supplier of medical products and diagnostics, including access, reimbursement, and supply chain considerations. |
| 2025-04-14 | BDX | BECTON DICKINSON AND COMPANY | SQUIRE PATTON BOGGS | $10K | General trade issues impacting medical technology. General trade issues impacting medical technology. |
| 2025-03-20 | BDX | BECTON DICKINSON AND COMPANY | BGR GOVERNMENT AFFAIRS | $0 | Provide strategic counsel and advocate on issues related to medical device regulation, supply chains and trade |
| 2025-02-19 | BDX | BECTON DICKINSON AND COMPANY | SQUIRE PATTON BOGGS | $0 | General issues impacting medical technology. General issues impacting medical technology. |
| 2025-01-21 | BDX | BECTON DICKINSON AND COMPANY | BECTON, DICKINSON AND COMPANY | $485K | Issues related to medical device sterilization Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to the National Defense Authorization Act Issues related to medical device supply chain Issues related to medical device reimbursement Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023 H.R.4261, ARC Act of 2023 Issues related to corporate taxation Tax incentives for domestic manufacturing |
| 2025-01-21 | BDX | BECTON DICKINSON AND COMPANY | KING & SPALDING LLP | $60K | Issues affecting manufacturer and direct supplier of medical products and diagnostics, including access, reimbursement, and supply chain considerations. |